Trying to put a true value on NWBO is like the average investor trying to put the ever expanding universe in a fixed size box. Once a majority of investors realize that Direct means NWBO does not need big pharma they will begin to understand the true big pharma dilema. This tech is not only for cancer but for many indications beyond that. Try finding enough zeros in any big pharma account for that. Best wishes.